Kevin Tracey, MD
President & CEO, Feinstein Institutes for Medical Research
Recorded: Thursday, June 18, 2020

Join Dr. Kevin Tracey, live Thursday, June 18, 2020, as he shares his perspective on ways to think about, deal with, and potentially treat the COVID-19 pandemic.
An expert in the methodology of drug testing, Dr. Kevin Tracey is the President and CEO of the Feinstein Institutes for Medical Research in Manhasset, NY, part of the Northwell School of Medicine at Hofstra University. He received his MD from Boston University and trained as a neurosurgeon at New York Hospital. He has led the Feinstein Institutes since 2005.
Dr. Tracey’s expertise in neuroscience and research on the molecular basis of inflammation led to the founding of the bioelectronics field, which seeks to modulate inflammation through electronic stimulation of neurons. He is recognized as one of the most-cited researchers in the world. As head of the Feinstein Institutes, Dr. Tracey is playing in a role in clinical trials run in partnership between Northwell Health and the pharmaceutical companies Gilead Sciences, Regeneron Pharmaceuticals, and Sanofi.
Get ready to join Dr. Kevin Tracey in conversation, Thursday, June 18th.
In the meantime, we invite you to take a moment now to help shape this upcoming conversation.
Check out the list of questions submitted by other registered attendees, and then vote to support any that match your interests.
Feel free to add your own question. Then spread the word to make sure others have the chance to help move your question to the top of the shared list.
-
Which drug holds the most promise ( other than Dexamethasone ) in this page http://www.marininfo.org/Healthcare/COVID-19/Drugs_Trials_COVID19.htm
votes